TFA Therapeutics, Inc. cotiza a 9.18 USD y tiene una capitalización bursátil de $1.0B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Consumo defensivo
TFA Therapeutics, Inc. develops TFA-01 novel nonsteroidal anti-inflammatory drugs for pet medical care. It offers drugs in the areas of canine osteoarthritis, dermatitis, and feline stomatitis. TFA Therapeutics, Inc. was formerly known as Cordyceps Sunshine Biotech Holdings Co., Ltd. and changed its name to TFA Therape…
| Métrica | RAJAF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 61.1% | 30.7% | +30.4% |
| Operating Margin | -11.3% | 1.0% | -12.4% |
| Net Margin | -12.4% | 0.8% | -13.2% |
| FCF Margin | — | 2.4% | — |
| ROE | — | 5.2% | — |
| ROA | -3.3% | 0.6% | -3.9% |
| Current Ratio | 0.19 | 1.35 | -1.16 |
| Debt / Equity | — | 0.37 | — |